Skip to main navigation Skip to search Skip to main content

Medical and procedural treatment of androgenetic alopecia – Where are we?

Research output: Contribution to journalReview articlepeer-review

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians’ fingertips.

Original languageEnglish (US)
Pages (from-to)S36-S39
JournalJournal of the American Academy of Dermatology
Volume89
Issue number2
DOIs
StatePublished - Aug 2023

Bibliographical note

Publisher Copyright:
© 2023

Keywords

  • androgenetic alopecia
  • finasteride
  • hair loss
  • hair transplantation
  • minoxidil
  • platelet-rich plasma

Fingerprint

Dive into the research topics of 'Medical and procedural treatment of androgenetic alopecia – Where are we?'. Together they form a unique fingerprint.

Cite this